Basal and postglucagon C-peptide levels in Nigerians with type 2 diabetes mellitus
dc.contributor.author | Coker, A.O | |
dc.contributor.author | Fasanmade, O.A | |
dc.contributor.author | Ohwovoriole, A.E | |
dc.date.accessioned | 2022-08-14T11:32:45Z | |
dc.date.available | 2022-08-14T11:32:45Z | |
dc.date.issued | 2007-09 | |
dc.description | Scholarly article | en_US |
dc.description.abstract | Objective To study basal C-peptide (BCP) and post glucagon C-peptide (PGCP) levels in Nigerians with type 2 diabetes mellitus. Methods A total of 40 subjects with type 2 diabetes and 20 control subjects were recruited from the Lagos University Teaching Hospital. BCP and PGCP were determined in all subjects. Results Mean+SEM BCP of 2.0+1.1ng/ml and 1.8+0.7 ng /ml in controls and subjects with diabetes was comparable. Mean +SEM post glucagon C-peptide (PGCP) and increment in C-peptide from basal was lower in subjects with diabetes compared with the control subjects (2.9 + 0.22 versus 5.6 + 0.5 and 1.14 +0.2 versus 3.6+0.32 respectively) p<0.05 and p<0.01. Among the subjects with diabetes, 2 had PGCP levels less than 1 ng/ml, and the mean increment in C-peptide was 0.03 and —0.06 ng/ml while 10(25%) had PGCP < 1.8ng/ml. Conclusion Post glucagon C-peptide levels are useful in reclassifying subjects Clinically defined as type 2 diabetes mellitus. | en_US |
dc.identifier.citation | Coker AO, Fasanmade OA, Ohwovoriole AE. Basal and post-glucagon C-peptide levels in Nigerians with type 2 diabetes mellitus. Nigerian Society of Endocrinology and Metabolism book of abstracts. Sept 2007. | en_US |
dc.identifier.uri | https://ir.unilag.edu.ng/handle/123456789/11049 | |
dc.language.iso | en | en_US |
dc.publisher | Nigerian Society of Endocrinology and Metabolism | en_US |
dc.subject | C-peptide, post-glucagon, Nigerians | en_US |
dc.subject | C-peptide | en_US |
dc.subject | post glucagon C-peptide (PGCP) | en_US |
dc.subject | type 2 diabetes mellitus. | en_US |
dc.subject | Nigerians | en_US |
dc.title | Basal and postglucagon C-peptide levels in Nigerians with type 2 diabetes mellitus | en_US |
dc.type | Presentation | en_US |